TSEM

Business Context and Reporting Period

Company: Tower Semiconductor Ltd. (Israel)

Reporting Period: Fiscal year ended December 31, 2008

Accounting Basis: US GAAP (transitioned from Israeli GAAP in Q4 2007)

Key Event: On September 19, 2008, Tower completed a stock-for-stock merger with Jazz Technologies, Inc. ("Jazz"), a U.S.-based specialty foundry. Jazz's results are consolidated from the merger date. The company operates two primary fabrication facilities: Fab 1 and Fab 2 in Israel, and Jazz's facility in Newport Beach, California.

Key Financial Metrics (Year Ended Dec 31, 2008)

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 9.0% to $251.7 million, driven by a 23.2% increase in wafer shipments and the inclusion of Jazz's results ($56.3 million) from September 19, 2008.
• Fixed Asset Impairment: A non-cash impairment charge of $120.5 million was recorded due to the global economic downturn, reduced demand, and downward price pressure in the semiconductor industry.
• Debt Restructuring Gain: A significant one-time gain of $130.7 million was recognized from the conversion of approximately $250 million of debt into equity-equivalent capital notes with banks and Israel Corporation (TIC).
• Net Loss Improvement: Despite the impairment charge, the net loss decreased by 20.7% compared to 2007, primarily due to the debt restructuring gain and reduced financing expenses.
• Equity Increase: Shareholders' equity increased significantly from $44.7 million to $110.3 million, largely due to the issuance of equity-equivalent capital notes and shares in connection with the debt restructuring and Jazz merger.

Guidance, Outlook, and Risks

Management Commentary: Management is executing a cost reduction plan targeting $80 million in annual savings. The company is exploring alternative funding sources, including asset sales and potential government grants, to mitigate the impact of the global economic downturn.

Outlook: The company expects to continue operating at a loss for the foreseeable future unless facility utilization rates increase significantly. Recovery depends on the broader economic recovery and semiconductor market demand.

Key Risks and Contingencies:

• Liquidity: Significant reliance on bank financing and potential inability to secure additional funding if market conditions worsen.
• Government Grants: Approximately $45 million in cash grants from the Israeli Investment Center are pending and overdue. Approval of an expansion plan is required to release these funds; failure to secure approval could materially adversely affect operations.
• Debt Covenants: The company is subject to strict financial covenants. While banks waived compliance through June 30, 2009, failure to meet future covenants could trigger immediate repayment of approximately $208 million in bank loans.
• Customer Concentration: Five customers accounted for a significant portion of revenues in 2008 (ranging from 5% to 17%).
• Legal Proceedings: An International Trade Commission (ITC) action was filed in 2008 alleging patent infringement, with potential material adverse effects.

Investor Verification Checklist

• Grant Status: Verify the current status of the $45 million pending Israeli Investment Center grants and the outcome of the High Court of Justice petition.
• Debt Covenants: Confirm compliance with financial covenants post-June 2009 and the status of negotiations for any further waivers.
• Utilization Rates: Assess current and projected wafer fabrication utilization rates at Fab 2 and Jazz facilities to evaluate the path to profitability.
• Cost Reduction: Review progress on the $80 million annual cost reduction plan.
• Legal Exposure: Monitor the status of the ITC patent infringement litigation and potential settlement costs.
• Share Dilution: Evaluate the potential dilution from the large number of outstanding warrants, options, and convertible notes (including equity-equivalent capital notes).